Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
The Preventive Medicine codes (99381-99412, 99429) do not need Modifier 25 to indicate a significant, separately identifiable service when reported in addition to the diagnostic and therapeutic Injection service
10.1371/journal.pone.0098915 214 YangN.GarciaM
After that, shots are given every 1-3 months
As a UK-based aod 9604 10mg supplier, Ascend Peptides UK provides these non-negotiable quality standards for every batch of the AOD-9604 10mg research peptide: HPLC purity verification: 98% confirmed by High-Performance Liquid Chromatography, batch-specific, from an independent analytical laboratory L C-MS molecular identity confirmation: Molecular weight verified to match expected AOD-9604 structure (C78H123N23O23S2, MW ~1,817 Da), including confirmation that the N-terminal tyrosine modification is intact Independent third-party testing: All testing performed by Janoshik, a specialist external analytical laboratory, not in-house Lyophilised powder format: Freeze-dried is the only format that maintains long-term stability for this peptide structure Full batch traceability: Complete documentation for publication referencing and institutional compliance reporting Research-only labelling: No health, cosmetic, or clinical claims, clear metabolic research peptide UK designation UK-based dispatch: Same-day shipping for orders placed before 4 pm, no international transit delays or stability risks Buy AOD-9604 10mg research peptide directly from Ascend Peptides UK, or explore our complete range of metabolic research peptides and scientific compounds, all dispatched same day for orders before 4 pm, with free shipping on orders over 50
Oral administration significantly reduces lipogenic activity and increases lipolytic activity in adipose tissue, with concurrent increases in fat and glucose oxidation and elevated energy expenditure
